TickerFacts.

Immuneering Corp (IMRX): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2023-12-31
$1.28M2020-12-31: $1.28M2021-12-31: $1.15M2022-12-31: $158.1K2023-12-31: $0$0
2020-12-31 Cost of Revenue (USD) 2023-12-31
Period endedCost of RevenueChange YoYSource filing
2023-12-31$0-100.0%2024-03-01, From 2023-01-01
2022-12-31$158.1K-86.3%2024-03-01, From 2022-01-01
2021-12-31$1.15M-9.9%2023-03-06, From 2021-01-01
2020-12-31$1.28Mn/a2022-03-10, From 2020-01-01